Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...

Imperial College London Diabetes Centre ICLDC part of the M42 group has signed two agreements to advance diabetes care highlighting its commitmen ...

When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even ...

During a fireside chat at the annual J.P. Morgan Healthcare Conference on January 13th, Mayo Clinic chief administrative ...

The healthcare IT market is driving digital transformation by enhancing efficiency, addressing workforce shortages, and ...

Brett A. Wall, Executive Vice President and President of Neuroscience at Medtronic plc (NYSE:MDT), a $118 billion market cap ...

If you’re rooting for a sweet mix of growth and dividends, these four US stocks should be on your radar. The post 4 Reputable ...

Beta Bionics, Inc. (BBNX) is planning to raise $112 million in an initial public offering on Thursday, January 30th, IPO Scoop reports. The company will be issuing 7,500,000 shares at $14.00-$16.00 ...

Neko Health has raised $260 million to expand a preventative healthcare service designed to detect cancers, cardiovascular ...

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

chief medical officer of the Diabetes Group at Medtronic. "The data demonstrating the benefits of this system are compelling and I'm confident it will simplify diabetes care for both patients and ...